NO874733L - Salt av diclofenac med en cyklisk organisk base, og farmasoeytiske preparater inneholdende dette. - Google Patents
Salt av diclofenac med en cyklisk organisk base, og farmasoeytiske preparater inneholdende dette.Info
- Publication number
- NO874733L NO874733L NO874733A NO874733A NO874733L NO 874733 L NO874733 L NO 874733L NO 874733 A NO874733 A NO 874733A NO 874733 A NO874733 A NO 874733A NO 874733 L NO874733 L NO 874733L
- Authority
- NO
- Norway
- Prior art keywords
- diclofenac
- salt
- organic base
- solvent
- cyclic
- Prior art date
Links
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 229960001259 diclofenac Drugs 0.000 title claims abstract description 30
- 150000003839 salts Chemical class 0.000 title claims abstract description 26
- 150000007530 organic bases Chemical class 0.000 title claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 title description 5
- 239000002904 solvent Substances 0.000 claims abstract description 8
- -1 cyclic organic base Chemical class 0.000 claims abstract description 6
- 239000003960 organic solvent Substances 0.000 claims abstract description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- KZTWONRVIPPDKH-UHFFFAOYSA-N 2-(piperidin-1-yl)ethanol Chemical compound OCCN1CCCCC1 KZTWONRVIPPDKH-UHFFFAOYSA-N 0.000 description 8
- XBRDBODLCHKXHI-UHFFFAOYSA-N epolamine Chemical compound OCCN1CCCC1 XBRDBODLCHKXHI-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8622320A IT1228242B (it) | 1986-11-13 | 1986-11-13 | Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO874733D0 NO874733D0 (no) | 1987-11-12 |
| NO874733L true NO874733L (no) | 1988-05-16 |
Family
ID=11194630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874733A NO874733L (no) | 1986-11-13 | 1987-11-12 | Salt av diclofenac med en cyklisk organisk base, og farmasoeytiske preparater inneholdende dette. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4948805A (fi) |
| EP (1) | EP0271709B1 (fi) |
| JP (1) | JPS63152372A (fi) |
| KR (1) | KR960003327B1 (fi) |
| AT (1) | ATE63304T1 (fi) |
| AU (1) | AU8117587A (fi) |
| CA (1) | CA1303050C (fi) |
| DE (1) | DE3769943D1 (fi) |
| DK (1) | DK592987A (fi) |
| ES (1) | ES2029254T3 (fi) |
| FI (1) | FI875023A (fi) |
| GR (1) | GR3002386T3 (fi) |
| IE (1) | IE873006L (fi) |
| IT (1) | IT1228242B (fi) |
| NO (1) | NO874733L (fi) |
| PT (1) | PT86121B (fi) |
| ZA (1) | ZA878405B (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229489B (it) * | 1988-12-09 | 1991-09-03 | Altergon Sa | Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile |
| JP3167327B2 (ja) * | 1990-11-19 | 2001-05-21 | アルベマール・コーポレーシヨン | 結晶性イブプロフェンの流れ特性を改良する方法 |
| IT1255007B (it) * | 1991-07-01 | 1995-10-11 | Altergon Sa | Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono. |
| JP3526887B2 (ja) * | 1993-04-23 | 2004-05-17 | 帝國製薬株式会社 | 消炎鎮痛外用貼付剤 |
| US5474985A (en) * | 1993-12-22 | 1995-12-12 | The Regents Of The University Of California | Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |
| DE4403943A1 (de) * | 1994-02-08 | 1995-08-10 | Hexal Pharma Gmbh | Orale Azrneimittelzubereitung mit Diclofenac-Natrium |
| HUT75341A (en) * | 1994-06-29 | 1997-05-28 | Ciba Geigy Ag | New salts of 2-[(2,6-dichloro-phenyl)-amino]-phenyl-acetoxy-acetic acid with organic bases, pharmaceutical compns. contg. them and process for preparing the said compds. |
| US5599535A (en) * | 1995-06-07 | 1997-02-04 | Regents Of The University Of California | Methods for the cyto-protection of the trabecular meshwork |
| US5674888A (en) * | 1995-06-07 | 1997-10-07 | University Of California | Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division |
| ITMI20030269A1 (it) * | 2003-02-14 | 2004-08-15 | Advance Holdings Ltd | Sale di cetilpiridino di un agente antiinfiammatorio |
| US7943668B2 (en) * | 2008-03-03 | 2011-05-17 | Altergon S.A. | Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained |
| WO2010069397A1 (en) * | 2008-12-19 | 2010-06-24 | Cosma S.P.A. | Process for the preparation of diclofenac epolamine |
| TWI482645B (zh) | 2010-01-07 | 2015-05-01 | Teikoku Seiyaku Kk | 含有待克菲那（ｄｉｃｌｏｆｅｎａｃ）羥乙基吡咯啶之外用油性敷貼劑 |
| ITMI20121205A1 (it) | 2012-07-11 | 2014-01-12 | Glycores 2000 Srl | Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione |
| US20220280463A1 (en) | 2019-09-09 | 2022-09-08 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
| IT202100016751A1 (it) | 2021-06-25 | 2022-12-25 | Altergon Sa | Formulazione topica di diclofenac ad elevato tasso di assorbimento |
| WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558690A (en) * | 1965-04-08 | 1971-01-26 | Gelgy Chemical Corp | Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation |
| LU83138A1 (de) * | 1981-02-16 | 1981-09-11 | T Eckert | Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung |
-
1986
- 1986-11-13 IT IT8622320A patent/IT1228242B/it active
-
1987
- 1987-11-09 EP EP87116513A patent/EP0271709B1/en not_active Expired - Lifetime
- 1987-11-09 ZA ZA878405A patent/ZA878405B/xx unknown
- 1987-11-09 US US07/117,823 patent/US4948805A/en not_active Expired - Lifetime
- 1987-11-09 ES ES198787116513T patent/ES2029254T3/es not_active Expired - Lifetime
- 1987-11-09 DE DE8787116513T patent/DE3769943D1/de not_active Expired - Fee Related
- 1987-11-09 IE IE873006A patent/IE873006L/xx unknown
- 1987-11-09 AT AT87116513T patent/ATE63304T1/de not_active IP Right Cessation
- 1987-11-12 AU AU81175/87A patent/AU8117587A/en not_active Abandoned
- 1987-11-12 CA CA000551717A patent/CA1303050C/en not_active Expired - Fee Related
- 1987-11-12 PT PT86121A patent/PT86121B/pt not_active IP Right Cessation
- 1987-11-12 KR KR1019870012712A patent/KR960003327B1/ko not_active IP Right Cessation
- 1987-11-12 DK DK592987A patent/DK592987A/da not_active Application Discontinuation
- 1987-11-12 NO NO874733A patent/NO874733L/no unknown
- 1987-11-13 FI FI875023A patent/FI875023A/fi not_active Application Discontinuation
- 1987-11-13 JP JP62285664A patent/JPS63152372A/ja active Granted
-
1991
- 1991-07-25 GR GR91401092T patent/GR3002386T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO874733D0 (no) | 1987-11-12 |
| DK592987D0 (da) | 1987-11-12 |
| ES2029254T3 (es) | 1992-08-01 |
| ZA878405B (en) | 1988-05-05 |
| JPS63152372A (ja) | 1988-06-24 |
| AU8117587A (en) | 1988-05-19 |
| DE3769943D1 (de) | 1991-06-13 |
| JPH0344062B2 (fi) | 1991-07-04 |
| PT86121B (pt) | 1990-08-31 |
| KR960003327B1 (ko) | 1996-03-08 |
| CA1303050C (en) | 1992-06-09 |
| EP0271709B1 (en) | 1991-05-08 |
| FI875023A (fi) | 1988-05-14 |
| KR880006218A (ko) | 1988-07-22 |
| DK592987A (da) | 1988-05-14 |
| PT86121A (en) | 1987-12-01 |
| US4948805A (en) | 1990-08-14 |
| EP0271709A1 (en) | 1988-06-22 |
| IE873006L (en) | 1988-05-13 |
| IT8622320A0 (it) | 1986-11-13 |
| FI875023A0 (fi) | 1987-11-13 |
| IT1228242B (it) | 1991-06-05 |
| GR3002386T3 (en) | 1992-12-30 |
| ATE63304T1 (de) | 1991-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO874733L (no) | Salt av diclofenac med en cyklisk organisk base, og farmasoeytiske preparater inneholdende dette. | |
| US4294828A (en) | New derivatives of 4-amino-5-alkyl sulphonyl orthoanisamides, methods of preparing them and their application as psychotropic agents | |
| KR100746813B1 (ko) | 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온의 하이드로클로라이드 염 | |
| KR850001883B1 (ko) | 결정성 벤조티아진 디옥시드 염류의 제조방법 | |
| DK200300345U3 (da) | Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat | |
| FR2462431A1 (fr) | Nouveau compose du guanidinothiazole, son procede de preparation et des compositions medicales contenant de tels composes | |
| FR2513250A1 (fr) | Nouvelles cyclobutene-3,4-diones substituees | |
| KR850001884B1 (ko) | 수용성 벤조티아진 디옥시드염류의 제조방법 | |
| US4767758A (en) | Pharmaceutical compositions containing thiophene compounds, and new thiophene compounds | |
| KR20090122218A (ko) | ５-(２,４-디히드록시-５-이소프로필-페닐)-４-(４-모르폴린-４-일메틸-페닐)-이속사졸-３-카르복실산 에틸아미드의 산 부가염, 수화물 및 다형체, 및 이들 형태를 포함하는 제제 | |
| KR100436254B1 (ko) | N-메틸-n[(1s)-1-페닐-2-((3s)-3-하이드록시피롤리딘-1-일)에틸]-2,2-디페닐아세트아미드 | |
| US5747521A (en) | N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same | |
| DE69215482T2 (de) | 2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum | |
| KR870000291B1 (ko) | 결정상 벤조티아진 디옥사이드 염의 제조방법 | |
| EP0015418B1 (en) | Process for the separation of the two optical isomers of 1-(o-methoxyphenoxy)-3-isopropylamino-propan-2-ol, optical isomers obtained thereby and pharmaceutical compositions of the levorotatory antipode thereof | |
| SU1122225A3 (ru) | Способ получени кристаллической водорастворимой негигроскопичной этилендиаминовой,моноэтаноламиновой или диэтаноламиновой соли @ -(2-пиридил)-2-метил-4-окси-2 @ -1,2-бензтиазин-3-карбоксамид-1,1-диоксида | |
| RU2177478C2 (ru) | Безводная кристаллическая форма гидрохлорида r(-)-n-(4,4-ди (3-метилтиен -2-ил) бут-3-енил)-нипекотиновой кислоты, способ ее получения, фармацевтическая композиция и способ лечения | |
| US4668674A (en) | (+)-6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)-acetyl]-11H-dibenzo[b,][1,4]diazepin-11-one, the isolation thereof and its use as a pharmaceutical material | |
| EP0053017A1 (en) | Amide derivatives | |
| EP0100815B1 (en) | N-(1,3-dithiolan-2-ylidene)anilines and their use as anti-inflammatory and anti-asthmatic agents | |
| JPS5865214A (ja) | Ｎ−アシル−ｌ−アスパルチルタウリンを含有する医薬 | |
| US4025550A (en) | Derivatives of triiodo-aminobenzenecarboxylic acids and the preparation thereof | |
| JPS5910563A (ja) | α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法 | |
| MXPA01012328A (es) | Polimorfos de un citrato de (2-benzhidril- 1-azabiciclo(2.2.2) oct-3-il- (5-iso- propil-2- metoxibencil) -amina como antagonistas del receptor de nk-1. | |
| JPH0211592A (ja) | 光学活性なジヒドロピリジンホスホン酸エステル |